Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 1
2007 4
2008 1
2009 1
2013 1
2015 1
2016 3
2017 4
2018 1
2019 1
2020 1
2022 1
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Low interleukin-2 concentration favors generation of early memory T cells over effector phenotypes during chimeric antigen receptor T-cell expansion.
Kaartinen T, Luostarinen A, Maliniemi P, Keto J, Arvas M, Belt H, Koponen J, Mäkinen PI, Loskog A, Mustjoki S, Porkka K, Ylä-Herttuala S, Korhonen M. Kaartinen T, et al. Cytotherapy. 2017 Jun;19(6):689-702. doi: 10.1016/j.jcyt.2017.03.067. Epub 2017 Apr 11. Cytotherapy. 2017. PMID: 28411126 Free article.
T cell regeneration in pediatric allogeneic stem cell transplantation.
Olkinuora H, Talvensaari K, Kaartinen T, Siitonen S, Saarinen-Pihkala U, Partanen J, Vettenranta K. Olkinuora H, et al. Among authors: kaartinen t. Bone Marrow Transplant. 2007 Feb;39(3):149-56. doi: 10.1038/sj.bmt.1705557. Epub 2007 Jan 8. Bone Marrow Transplant. 2007. PMID: 17211435
Immunomonitoring of MSC-Treated GvHD Patients Reveals Only Moderate Potential for Response Prediction but Indicates Treatment Safety.
Keto J, Kaartinen T, Salmenniemi U, Castrén J, Partanen J, Hänninen A, Korhonen M, Lähteenmäki K, Itälä-Remes M, Nystedt J. Keto J, et al. Among authors: kaartinen t. Mol Ther Methods Clin Dev. 2018 Feb 8;9:109-118. doi: 10.1016/j.omtm.2018.02.001. eCollection 2018 Jun 15. Mol Ther Methods Clin Dev. 2018. PMID: 29516024 Free PMC article.
Optimizing lentiviral vector formulation conditions for efficient ex vivo transduction of primary human T cells in chimeric antigen receptor T-cell manufacturing.
Luostarinen A, Kailaanmäki A, Turkki V, Köylijärvi M, Käyhty P, Leinonen H, Albers-Skirdenko V, Lipponen E, Ylä-Herttuala S, Kaartinen T, Lesch HP, Kekarainen T. Luostarinen A, et al. Among authors: kaartinen t. Cytotherapy. 2024 Apr 7:S1465-3249(24)00600-5. doi: 10.1016/j.jcyt.2024.04.002. Online ahead of print. Cytotherapy. 2024. PMID: 38661611 Free article.
ATMP-classified, scalable, autologous cell spray for the treatment of skin wounds and assessment of its effects on wound healing clinically and on a molecular level.
Nuutila K, Katayama S, Laitinen A, Siltanen A, Patrikoski M, Valtonen J, Kankainen M, Kerkelä E, Kaartinen T, Juteau S, Korhonen M, Vuola J, Kankuri E. Nuutila K, et al. Among authors: kaartinen t. Burns. 2023 Aug;49(5):1144-1156. doi: 10.1016/j.burns.2022.09.006. Epub 2022 Sep 16. Burns. 2023. PMID: 36195485 Free article.
Low interleukin-2 concentration favors generation of early memory T cells over effector phenotypes during chimeric antigen receptor T-cell expansion.
Kaartinen T, Luostarinen A, Maliniemi P, Keto J, Arvas M, Belt H, Koponen J, Mäkinen PI, Loskog A, Mustjoki S, Porkka K, Ylä-Herttuala S, Korhonen M. Kaartinen T, et al. Cytotherapy. 2017 Sep;19(9):1130. doi: 10.1016/j.jcyt.2017.06.003. Epub 2017 Jun 20. Cytotherapy. 2017. PMID: 28645733 No abstract available.
18 results